• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HeartMate II、HeartMate 3和BrioVAD对剪切诱导的血液损伤的计算与实验评估

Computational and Experimental Assessment of Shear-Induced Blood Trauma by HeartMate II, HeartMate 3, and BrioVAD.

作者信息

Tarafder Anik, Han Dong, Griffith Bartley P, Wu Zhongjun J

机构信息

From the Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland.

Fischell Department of Bioengineering, A. James Clark School of Engineering, University of Maryland, College Park, Maryland.

出版信息

ASAIO J. 2025 Jun 23. doi: 10.1097/MAT.0000000000002487.

DOI:10.1097/MAT.0000000000002487
PMID:40548579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12406701/
Abstract

Although durable mechanical circulatory support (MCS) has been promising in supporting advanced heart failure patients, device hemocompatibility-related complications remain a major concern compared with heart transplantation. We investigated the blood damage potential of the three most recent clinically available, implantable MCS devices and compared their biocompatibility performance. One axial pump (HeartMate II) and two centrifugal pumps (HeartMate 3 and BrioVAD) were chosen for this study. In vitro experiments with healthy human blood and computational fluid dynamics simulations were performed to compare high-mechanical shear-induced blood trauma in these devices. Regions of higher shear stresses were identified. Power-law relations between shear stress and blood damage were implemented to assess hemolysis, platelet activation, and platelet receptor shedding of key functional receptors (glycoprotein [GP] Ibα, and GPVI) caused by these devices. HeartMate II caused the most severe blood trauma among these three devices, producing an order of magnitude larger values for hemolysis and platelet activation compared with HeartMate 3 and BrioVAD. Also, HeartMate II consistently exhibited the highest levels of receptor shedding, approximately double those caused by the HeartMate 3 and BrioVAD. The HeartMate 3 and BrioVAD centrifugal pumps showed similar performance in terms of blood damage.

摘要

尽管持久的机械循环支持(MCS)在支持晚期心力衰竭患者方面前景广阔,但与心脏移植相比,与设备血液相容性相关的并发症仍然是一个主要问题。我们研究了三种最新临床可用的可植入MCS设备的血液损伤潜力,并比较了它们的生物相容性性能。本研究选择了一台轴流泵(HeartMate II)和两台离心泵(HeartMate 3和BrioVAD)。进行了健康人血液的体外实验和计算流体动力学模拟,以比较这些设备中高机械剪切诱导的血液损伤。确定了较高剪切应力区域。采用剪切应力与血液损伤之间的幂律关系来评估这些设备引起的溶血、血小板活化以及关键功能受体(糖蛋白[GP]Ibα和GPVI)的血小板受体脱落。在这三种设备中,HeartMate II造成的血液损伤最严重,与HeartMate 3和BrioVAD相比,其溶血和血小板活化值高出一个数量级。此外,HeartMate II始终表现出最高水平的受体脱落,约为HeartMate 3和BrioVAD引起的受体脱落水平的两倍。HeartMate 3和BrioVAD离心泵在血液损伤方面表现出相似的性能。

相似文献

1
Computational and Experimental Assessment of Shear-Induced Blood Trauma by HeartMate II, HeartMate 3, and BrioVAD.HeartMate II、HeartMate 3和BrioVAD对剪切诱导的血液损伤的计算与实验评估
ASAIO J. 2025 Jun 23. doi: 10.1097/MAT.0000000000002487.
2
In Vitro Comparison of Device-Induced Hemolysis, Platelet Defects, and von Willebrand Factor Degradation Between the HeartMate 2 and HeartMate 3 Pumps.HeartMate 2和HeartMate 3泵之间装置诱导的溶血、血小板缺陷及血管性血友病因子降解的体外比较
Artif Organs. 2025 Apr 24. doi: 10.1111/aor.15013.
3
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.左心室辅助装置作为晚期心力衰竭的终末期治疗的临床和成本效益:系统评价和经济评估。
Health Technol Assess. 2024 Aug;28(38):1-237. doi: 10.3310/MLFA4009.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.终末期心力衰竭患者使用左心室辅助装置的临床疗效及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450.
6
A Biophysics-Based Mathematical Model of Shear-Induced Platelet Activation and Receptor Shedding: Re-Examining Previous Experimental Data.基于生物物理学的剪切诱导血小板活化和受体脱落的数学模型:重新审视先前的实验数据。
ASAIO J. 2025 Aug 1;71(8):621-627. doi: 10.1097/MAT.0000000000002399. Epub 2025 Feb 19.
7
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.第二代和第三代左心室辅助装置作为适合心脏移植的成人移植桥接或替代治疗的临床效果和成本效益:系统评价和成本效益模型。
Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530.
8
Empirical and Computational Evaluation of Hemolysis in a Microfluidic Extracorporeal Membrane Oxygenator Prototype.微流控体外膜肺氧合原型中溶血的实验与计算评估
Micromachines (Basel). 2024 Jun 15;15(6):790. doi: 10.3390/mi15060790.
9
Design and rationale for the clinical investigation of a novel, magnetically levitated left ventricular assist device for the treatment of refractory heart failure.
J Heart Lung Transplant. 2025 Aug;44(8):1290-1299. doi: 10.1016/j.healun.2025.03.001. Epub 2025 Mar 8.
10
In vitro study on device-induced damage to blood cellular components and degradation of von Willebrand factor in a CentriMag pump-assisted circulation.体外研究离心泵辅助循环中血细胞成分的器械损伤和 von Willebrand 因子的降解。
Artif Organs. 2024 Sep;48(9):988-996. doi: 10.1111/aor.14766. Epub 2024 May 7.

本文引用的文献

1
Design and rationale for the clinical investigation of a novel, magnetically levitated left ventricular assist device for the treatment of refractory heart failure.
J Heart Lung Transplant. 2025 Aug;44(8):1290-1299. doi: 10.1016/j.healun.2025.03.001. Epub 2025 Mar 8.
2
Turbulent flow field in maglev centrifugal blood pumps of CH-VAD and HeartMate III: secondary flow and its effects on pump performance.CH-VAD和HeartMate III磁悬浮离心式血泵中的湍流流场:二次流及其对泵性能的影响。
Biomech Model Mechanobiol. 2024 Oct;23(5):1571-1589. doi: 10.1007/s10237-024-01855-1. Epub 2024 May 31.
3
Linking Computational Fluid Dynamics Modeling to Device-Induced Platelet Defects in Mechanically Assisted Circulation.将计算流体动力学建模与机械辅助循环中装置诱导的血小板缺陷相联系。
ASAIO J. 2024 Dec 1;70(12):1085-1093. doi: 10.1097/MAT.0000000000002242. Epub 2024 May 19.
4
In vitro study on device-induced damage to blood cellular components and degradation of von Willebrand factor in a CentriMag pump-assisted circulation.体外研究离心泵辅助循环中血细胞成分的器械损伤和 von Willebrand 因子的降解。
Artif Organs. 2024 Sep;48(9):988-996. doi: 10.1111/aor.14766. Epub 2024 May 7.
5
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.阿司匹林与左心室辅助装置在晚期心力衰竭中的血液相容性事件:ARIES-HM3 随机临床试验。
JAMA. 2023 Dec 12;330(22):2171-2181. doi: 10.1001/jama.2023.23204.
6
Hemocompatibility and hemodynamic comparison of two centrifugal LVADs: HVAD and HeartMate3.两种离心式 LVAD 的血液相容性和血液动力学比较:HVAD 和 HeartMate3。
Biomech Model Mechanobiol. 2023 Jun;22(3):871-883. doi: 10.1007/s10237-022-01686-y. Epub 2023 Jan 17.
7
A Comprehensive Review of Mechanical Circulatory Support Devices.机械循环支持设备的全面综述
Heart Int. 2022 Mar 4;16(1):37-48. doi: 10.17925/HI.2022.16.1.37. eCollection 2022.
8
Computational fluid dynamics analysis and experimental hemolytic performance of three clinical centrifugal blood pumps: Revolution, Rotaflow and CentriMag.三款临床离心式血泵的计算流体动力学分析及体外溶血性能:Revolution、Rotaflow和CentriMag
Med Nov Technol Devices. 2022 Sep;15. doi: 10.1016/j.medntd.2022.100153. Epub 2022 Jun 19.
9
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.在 MOMENTUM 3 随机试验中,完全磁悬浮与轴流左心室辅助装置患者的 5 年结果。
JAMA. 2022 Sep 27;328(12):1233-1242. doi: 10.1001/jama.2022.16197.
10
Discrete responses of erythrocytes, platelets, and von Willebrand factor to shear.红细胞、血小板和血管性血友病因子对切变的离散反应。
J Biomech. 2022 Jan;130:110898. doi: 10.1016/j.jbiomech.2021.110898. Epub 2021 Dec 6.